Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

Bloomberg Brief Weekly Video 11/25
12:17 - Taylor Riggs, a contributor to Bloomberg Briefs, talks with reporter Joe Mysak about this week's municipal market news. (Source: Bloomberg)
  • The Battle Between Fantasy Sports and States
  • Brazil Corruption Probe Nets BTG Pactual CEO Esteves
  • HP Paints Grim PC Picture in Final Earnings Report